JOHN L. HIGGINS - 28 Dec 2022 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
Director
Signature
/s/ Andrew Reardon, Attorney-in-Fact for John L. Higgins
Issuer symbol
LGND
Transactions as of
28 Dec 2022
Transactions value $
-$350,608
Form type
4
Filing time
30 Dec 2022, 16:00:13 UTC
Previous filing
27 Dec 2022
Next filing
01 Feb 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Tax liability -$351K -5.29K -1.25% $66.29 418K 28 Dec 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.